Una píldora anticonceptiva masculina no hormonal nueva es altamente efectiva en los ratones y podrían comenzar las pruebas en humanos en el 2022, según los investigadores.
Related Posts
Eye-Tracking Device Could Be More Accurate Test for Autism in Toddlers
TUESDAY, Sept. 5, 2023 (HealthDay News) -- Just 1 in 4 children with autism is...
AHA News: A Thump to His Chest During a Game Stopped His Heart. Textbook Response Saved Him.
TUESDAY, Jan. 24, 2023 (American Heart Association News) -- On April 16, 2021,...
ACC: Treatment Beneficial for Mild Chronic HTN in Pregnancy
TUESDAY, April 5, 2022 (HealthDay News) -- For pregnant women with mild chronic...